Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on lipid-lowering therapy

J D Barth1, G B Mancini

  • 1Division of Cardiology, Vancouver Hospital and Health Sciences Centre, University of British Columbia, Canada.

Current Opinion in Lipidology
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sonographic reproducibility of a novel approach in the assessment of centralised access in end-stage renal disease.

International journal of clinical practice·2003
Same author

Anterior shoulder dislocation and injuries of the rotator cuff in patients aged over 40 years. Clinical and sonographic study.

La Chirurgia degli organi di movimento·2002
Same author

Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.

Cardiovascular drugs and therapy·2002
Same author

Quinapril ischemic event trial.

The American journal of cardiology·2001
Same author

IMT for the elderly?

Stroke·2001
Same author

Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).

American heart journal·2001
Same journal

Editorial introduction.

Current opinion in lipidology·2026
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
See all related articles

Lipid-lowering drugs, particularly HMG-CoA reductase inhibitors, are effective for diverse populations. Enhancing drug effectiveness requires addressing patient compliance with both diet and medication.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Lipid-lowering drugs play a crucial role in managing hyperlipidemia.
  • Patient adherence to both medication and dietary recommendations is vital for treatment success.
  • Individual responses to dietary interventions vary significantly and require further investigation.

Purpose of the Study:

  • To review current information on lipid-lowering drug efficacy.
  • To highlight benefits of specific drug therapies in special patient populations.
  • To emphasize the importance of compliance and individual variability in treatment outcomes.

Main Methods:

  • Literature review focusing on lipid-lowering drug effects.
  • Analysis of drug efficacy in diverse groups including women, the elderly, and those with secondary hyperlipidemia.

Related Experiment Videos

  • Discussion of the interplay between diet, drug compliance, and therapeutic outcomes.

    • Main Results:

    • 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors demonstrate safety and effectiveness across various populations.
    • Diet can augment the effects of lipid-lowering medications, but compliance remains a challenge.
    • Individual variations in dietary response necessitate further research.

    Conclusions:

    • Lipid-lowering drugs, especially statins, offer significant benefits for specific patient groups.
    • Improving adherence to both pharmacological and lifestyle interventions is key to optimizing cardiovascular health.
    • Widespread screening for lipid-lowering therapy can improve resource allocation in healthcare.